WHO: 21.3m Africans on Antiretroviral Treatment as HIV Infections Decline

The World Health Organisation,(WHO) celebrated a milestone in the fight against HIV in sub-Saharan Africa, where 21.3 million people are now receiving antiretroviral treatment (ART), leading to substantial reductions in both new infections and HIV-related deaths.

Dr. Matshidiso Moeti, WHO Regional Director for Africa, highlighted these gains on Friday in a message issued ahead of the 2024 World AIDS Day,

marking the region’s progress toward the ambitious goal of eliminating HIV by 2030.

“Over the past decade, sub-Saharan Africa has made remarkable strides in HIV care,” Dr. Moeti stated. “The number of new infections has been significantly reduced, and for the first time in 2023, the number of new HIV cases outside Africa surpassed those within the region.”

Despite having the highest HIV burden globally, African countries have outpaced many others in addressing the epidemic, achieving reductions in new infections and AIDS-related deaths through expanded access to treatment and innovative prevention measures.

Dr. Moeti also stated the impact of antiretroviral therapy, which has helped improve the quality of life for millions across the continent. “With 21.3 million people now on ART, we are seeing increased life expectancy and better health outcomes for those living with HIV,” she noted.

She added that countries like Botswana and Namibia have been recognised for their success in significantly reducing mother-to-child transmission, reaching critical indicators for the “Path to Elimination of HIV” initiative.

While progress is evident, Dr. Moeti cautioned that challenges remain, particularly in overcoming stigma and ensuring universal access to care. “We must remain committed to protecting human rights and ensuring that healthcare is accessible to all, regardless of their HIV status,” she said.

Discover more from Africa Health Report

Subscribe now to keep reading and get access to the full archive.

Continue reading